Terms: = Pancreatic cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306
23 results:
1. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
2. Cell-in-Cell-Mediated Entosis Reveals a Progressive Mechanism in pancreatic cancer.
Song J; Xu R; Zhang H; Xue X; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
Gastroenterology; 2023 Dec; 165(6):1505-1521.e20. PubMed ID: 37657757
[TBL] [Abstract] [Full Text] [Related]
3. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract] [Full Text] [Related]
4. The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids.
Choi JI; Rim JH; Jang SI; Park JS; Park H; Cho JH; Lim JB
Theranostics; 2022; 12(9):4431-4445. PubMed ID: 35673567
[No Abstract] [Full Text] [Related]
5. A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in pancreatic cancer.
Xiao M; Liang X; Yan Z; Chen J; Zhu Y; Xie Y; Li Y; Li X; Gao Q; Feng F; Fu G; Gao Y
Front Immunol; 2022; 13():803962. PubMed ID: 35222383
[TBL] [Abstract] [Full Text] [Related]
6. Extracellular vesicles in pancreatic cancer progression and therapies.
Chang CH; Pauklin S
Cell Death Dis; 2021 Oct; 12(11):973. PubMed ID: 34671031
[TBL] [Abstract] [Full Text] [Related]
7. Deep Targeted Sequencing and Its Potential Implication for cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Capicua on pancreatic cancer Progression.
Yoshiya S; Itoh S; Yoshizumi T; Yugawa K; Kurihara T; Toshima T; Harada N; Hashisako M; Yonemasu H; Fukuzawa K; Oda Y; Mori M
Ann Surg Oncol; 2021 Jun; 28(6):3198-3207. PubMed ID: 33216264
[TBL] [Abstract] [Full Text] [Related]
9. Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma.
Hayashi A; Yavas A; McIntyre CA; Ho YJ; Erakky A; Wong W; Varghese AM; Melchor JP; Overholtzer M; O'Reilly EM; Klimstra DS; Basturk O; Iacobuzio-Donahue CA
Mod Pathol; 2020 Sep; 33(9):1822-1831. PubMed ID: 32350415
[TBL] [Abstract] [Full Text] [Related]
10. Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly.
Kyuno D; Bauer N; Schnölzer M; Provaznik J; Ryschich E; Hackert T; Zöller M
Int J Biol Sci; 2019; 15(10):2224-2239. PubMed ID: 31592143
[TBL] [Abstract] [Full Text] [Related]
11. Exosomes, metastases, and the miracle of cancer stem cell markers.
Wang Z; Zöller M
Cancer Metastasis Rev; 2019 Jun; 38(1-2):259-295. PubMed ID: 31030373
[TBL] [Abstract] [Full Text] [Related]
12. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
[TBL] [Abstract] [Full Text] [Related]
13. pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.
Wang Z; Sun H; Provaznik J; Hackert T; Zöller M
J Exp Clin Cancer Res; 2019 Mar; 38(1):132. PubMed ID: 30890157
[TBL] [Abstract] [Full Text] [Related]
14.
Kasten BB; Gangrade A; Kim H; Fan J; Ferrone S; Ferrone CR; Zinn KR; Buchsbaum DJ
Nucl Med Biol; 2018 Mar; 58():67-73. PubMed ID: 29413459
[TBL] [Abstract] [Full Text] [Related]
15. ATXN1L, cic, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.
Wang B; Krall EB; Aguirre AJ; Kim M; Widlund HR; Doshi MB; Sicinska E; Sulahian R; Goodale A; Cowley GS; Piccioni F; Doench JG; Root DE; Hahn WC
Cell Rep; 2017 Feb; 18(6):1543-1557. PubMed ID: 28178529
[TBL] [Abstract] [Full Text] [Related]
16. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.
Wang Z; von Au A; Schnölzer M; Hackert T; Zöller M
Oncotarget; 2016 Aug; 7(34):55409-55436. PubMed ID: 27419629
[TBL] [Abstract] [Full Text] [Related]
17. Exosomes in cancer Disease.
Zöller M
Methods Mol Biol; 2016; 1381():111-49. PubMed ID: 26667458
[TBL] [Abstract] [Full Text] [Related]
18. Effect of Wnt inhibitors in pancreatic cancer.
Wall I; Schmidt-Wolf IG
Anticancer Res; 2014 Oct; 34(10):5375-80. PubMed ID: 25275031
[TBL] [Abstract] [Full Text] [Related]
19. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
Wang H; Rana S; Giese N; Büchler MW; Zöller M
Int J Cancer; 2013 Jul; 133(2):416-26. PubMed ID: 23338841
[TBL] [Abstract] [Full Text] [Related]
20. CD44 and EpCAM: cancer-initiating cell markers.
Marhaba R; Klingbeil P; Nuebel T; Nazarenko I; Buechler MW; Zoeller M
Curr Mol Med; 2008 Dec; 8(8):784-804. PubMed ID: 19075676
[TBL] [Abstract] [Full Text] [Related]
[Next]
